Advances in the medical treatment of pulmonary hypertension (Q36420236)

14 August 2017

1 reference

title

Advances in the medical treatment of pulmonary hypertension (English)

1 reference

14 August 2017

3

Roland Hetzer

1 reference

14 August 2017

1

Michael Dandel

1 reference

14 August 2017

Hans Brendan Lehmkuhl

series ordinal

2

object named as

Hans B Lehmkuhl

1 reference

14 August 2017

publication date

1 January 2005

1 reference

Kidney and Blood Pressure Research

14 August 2017

published in

1 reference

14 August 2017

volume

28

1 reference

14 August 2017

issue

5-6

1 reference

14 August 2017

page(s)

311-324

1 reference

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

14 August 2017

cites work

1 reference

Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?

21 January 2018

1 reference

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension

21 January 2018

1 reference

Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study

21 January 2018

1 reference

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

21 January 2018

1 reference

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

21 January 2018

1 reference

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

21 January 2018

1 reference

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

21 January 2018

1 reference

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

21 January 2018

1 reference

Prostanoids for pulmonary arterial hypertension.

21 January 2018

1 reference

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

21 January 2018

1 reference

21 January 2018

Noninvasive Ventilation

1 reference

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

EndothelinB receptor-mediated contraction in human pulmonary resistance arteries

21 January 2018

1 reference

Acute pro‐inflammatory actions of endothelin‐1 in the guinea‐pig lung: involvement of ETA and ETB receptors

21 January 2018

1 reference

Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension

21 January 2018

1 reference

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

21 January 2018

1 reference

Sildenafil modulates hemodynamics and pulmonary gas exchange

21 January 2018

1 reference

Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review

21 January 2018

1 reference

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee

21 January 2018

1 reference

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

21 January 2018

1 reference

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

21 January 2018

1 reference

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

21 January 2018

1 reference

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

Short-term Pulmonary Vasodilation With l -Arginine in Pulmonary Hypertension

21 January 2018

1 reference

Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension

21 January 2018

1 reference

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

Combined treatment with intravenous prostacyclin and sildenafil in patients with pulmonary hypertension: report of 4 cases

21 January 2018

1 reference

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms

21 January 2018

1 reference

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000090186

1 reference

14 August 2017

1 reference